Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics.
Wilken
Jason A
JA
Yale University, School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, PO Box 208063, 310 Cedar Street, New Haven, CT 06520-8063, USA. nita.maihle@yale.edu.
Webster
Kristy T
KT
Maihle
Nita J
NJ